AB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosis
15/01/2024 – AB Science today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating severe systemic mastocytosis with its lead compound masitinib, based on findings from study AB06006